Micrornas in endometrial cancer

Recent advances and potential clinical applications

Megumi Yanokura, Kouji Banno, Miho Iida, Haruko Irie, Kiyoko Umene, Kenta Masuda, Yusuke Kobayashi, Eiichirou Tominaga, Daisuke Aoki

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregulation in cells may permit effective and minimally invasive diagnosis and treatment. In endometrial cancer cells, expression levels of miRNAs including miR-185, miR-210 and miR-423 are upregulat-ed and those of miR-let7e, miR-30c and miR-221 are downregulated compared to normal tissues, and these miRNAs are involved in carcinogenesis, invasion and metastasis. miRNAs with expression changes such as miR-181b, miR-324-3p and miR-518b may be used as prognostic biomarkers and transfection of miR-152 may inhibit cancer growth. However, most current studies of miRNAs are at a basic level and further work is needed to establish clinical applications targeting miRNAs.

Original languageEnglish
Pages (from-to)190-198
Number of pages9
JournalEXCLI Journal
Volume14
DOIs
Publication statusPublished - 2015 Feb 2

Fingerprint

Endometrial Neoplasms
MicroRNAs
microRNA
neoplasms
biomarkers
Down-Regulation
transfection
Tumor Biomarkers
metastasis
carcinogenesis
Transfection
Early Diagnosis
Carcinogenesis
surgery
Biomarkers
Neoplasm Metastasis
Growth
Genes
Neoplasms
genes

Keywords

  • Biomarker
  • Endometrial cancer
  • MicroRNA
  • OncomiR
  • Tumor suppressor miR

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Animal Science and Zoology

Cite this

Micrornas in endometrial cancer : Recent advances and potential clinical applications. / Yanokura, Megumi; Banno, Kouji; Iida, Miho; Irie, Haruko; Umene, Kiyoko; Masuda, Kenta; Kobayashi, Yusuke; Tominaga, Eiichirou; Aoki, Daisuke.

In: EXCLI Journal, Vol. 14, 02.02.2015, p. 190-198.

Research output: Contribution to journalArticle

@article{935b9f88f0fd478e8e12d0a6701a2167,
title = "Micrornas in endometrial cancer: Recent advances and potential clinical applications",
abstract = "Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregulation in cells may permit effective and minimally invasive diagnosis and treatment. In endometrial cancer cells, expression levels of miRNAs including miR-185, miR-210 and miR-423 are upregulat-ed and those of miR-let7e, miR-30c and miR-221 are downregulated compared to normal tissues, and these miRNAs are involved in carcinogenesis, invasion and metastasis. miRNAs with expression changes such as miR-181b, miR-324-3p and miR-518b may be used as prognostic biomarkers and transfection of miR-152 may inhibit cancer growth. However, most current studies of miRNAs are at a basic level and further work is needed to establish clinical applications targeting miRNAs.",
keywords = "Biomarker, Endometrial cancer, MicroRNA, OncomiR, Tumor suppressor miR",
author = "Megumi Yanokura and Kouji Banno and Miho Iida and Haruko Irie and Kiyoko Umene and Kenta Masuda and Yusuke Kobayashi and Eiichirou Tominaga and Daisuke Aoki",
year = "2015",
month = "2",
day = "2",
doi = "10.17179/excli2014-590",
language = "English",
volume = "14",
pages = "190--198",
journal = "EXCLI Journal",
issn = "1611-2156",
publisher = "University of Mainz",

}

TY - JOUR

T1 - Micrornas in endometrial cancer

T2 - Recent advances and potential clinical applications

AU - Yanokura, Megumi

AU - Banno, Kouji

AU - Iida, Miho

AU - Irie, Haruko

AU - Umene, Kiyoko

AU - Masuda, Kenta

AU - Kobayashi, Yusuke

AU - Tominaga, Eiichirou

AU - Aoki, Daisuke

PY - 2015/2/2

Y1 - 2015/2/2

N2 - Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregulation in cells may permit effective and minimally invasive diagnosis and treatment. In endometrial cancer cells, expression levels of miRNAs including miR-185, miR-210 and miR-423 are upregulat-ed and those of miR-let7e, miR-30c and miR-221 are downregulated compared to normal tissues, and these miRNAs are involved in carcinogenesis, invasion and metastasis. miRNAs with expression changes such as miR-181b, miR-324-3p and miR-518b may be used as prognostic biomarkers and transfection of miR-152 may inhibit cancer growth. However, most current studies of miRNAs are at a basic level and further work is needed to establish clinical applications targeting miRNAs.

AB - Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregulation in cells may permit effective and minimally invasive diagnosis and treatment. In endometrial cancer cells, expression levels of miRNAs including miR-185, miR-210 and miR-423 are upregulat-ed and those of miR-let7e, miR-30c and miR-221 are downregulated compared to normal tissues, and these miRNAs are involved in carcinogenesis, invasion and metastasis. miRNAs with expression changes such as miR-181b, miR-324-3p and miR-518b may be used as prognostic biomarkers and transfection of miR-152 may inhibit cancer growth. However, most current studies of miRNAs are at a basic level and further work is needed to establish clinical applications targeting miRNAs.

KW - Biomarker

KW - Endometrial cancer

KW - MicroRNA

KW - OncomiR

KW - Tumor suppressor miR

UR - http://www.scopus.com/inward/record.url?scp=84928236867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928236867&partnerID=8YFLogxK

U2 - 10.17179/excli2014-590

DO - 10.17179/excli2014-590

M3 - Article

VL - 14

SP - 190

EP - 198

JO - EXCLI Journal

JF - EXCLI Journal

SN - 1611-2156

ER -